Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients

Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients

Abstract Aim To investigate the impact of biological subtypes in locoregional recurrence in Chinese breast cancer patients receiving postmastectomy radiotherapy (PMRT). Methods and Materials About 583 patients who received postmastectomy radiation between 2010 and 2012 were retrospectively analyzed....

Bibliografske podrobnosti
Main Authors:	Jiangfeng Wang, Jurui Luo, Kairui Jin, Xuanyi Wang, Zhaozhi Yang, Jinli Ma, Xin Mei, Xiaofang Wang, Zhirui Zhou, Xiaoli Yu, Xingxing Chen, Xiaomao Guo
Format:	Article
Jezik:	English
Izdano:	Wiley 2020-04-01
Serija:	Cancer Medicine
Teme:	biological subtype breast cancer radiotherapy recurrence
Online dostop:	https://doi.org/10.1002/cam4.2904

Podobne knjige/članki

Postmastectomy radiotherapy and locoregional recurrence rate in high-risk breast cancer patients
od: Šćepanović Danijela S., et al.
Izdano: (2004-01-01)

The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
od: Jinli Wei, et al.
Izdano: (2020-06-01)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer
od: Aline Van der Vorst, et al.
Izdano: (2022-08-01)

Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery
od: Yilan Yang, et al.
Izdano: (2022-07-01)

Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes
od: Xin-Yuan Guo, et al.
Izdano: (2022-02-01)

Outcomes with and without postmastectomy radiotherapy for pT3N0‐1M0 breast cancer: An institutional experience
od: Xinxin Rao, et al.
Izdano: (2024-01-01)

ISOLATED LOCOREGIONAL RECURRENCE IN PATIENTS WITH POSTMASTECTOMY ADJUVANT THERAPY FOR BREAST CANCER
od: Cengizhan Yiğitler, et al.
Izdano: (2010-04-01)

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
od: Wang X, et al.
Izdano: (2018-10-01)

Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy
od: Moonkyoo Kong, et al.
Izdano: (2022-09-01)

Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial
od: Kairui Jin, et al.
Izdano: (2024-05-01)

Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature
od: Ciro Franzese, et al.
Izdano: (2024-05-01)

Radiotherapy for Recurrent Keloid: A Case Report
od: Christina Hari Nawangsih Prihharsanti, et al.
Izdano: (2020-12-01)

CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
od: Yilan Yang, et al.
Izdano: (2020-09-01)

Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy
od: Dechao Feng, et al.
Izdano: (2022-04-01)

Pattern of local recurrence and metastasis in carcinoma breast according to molecular subtype in patients treated with definitive intent
od: Samantha Adriana Dsouza, et al.
Izdano: (2022-01-01)

Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion
od: Chunyan Li, et al.
Izdano: (2021-10-01)

Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis
od: Minjie Shan, et al.
Izdano: (2023-09-01)

Patterns of Chest Wall Recurrence and Suggestions on the Clinical Target Volume of Breast Cancer: A Retrospective Analysis of 121 Postmastectomy Patients
od: Wang LW, et al.
Izdano: (2020-07-01)

Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients
od: Khazaeipour Zahra, et al.
Izdano: (2010-04-01)

The impact of histological subtype on postoperative recurrence pattern and timing in locally advanced esophagogastric junction cancer
od: Shinsuke Maeda, et al.
Izdano: (2024-09-01)

Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer
od: Shi W, et al.
Izdano: (2019-05-01)

A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients
od: Kartick Rastogi, et al.
Izdano: (2018-01-01)

Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
od: Moonkyoo Kong, et al.
Izdano: (2021-11-01)

Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapy
od: Pan Gong, et al.
Izdano: (2022-12-01)

Comparison of the Dosimetric Benefits of Two Different Three-dimensional Conformal Radiotherapy Treatment Approaches for Postmastectomy Radiotherapy
od: Bharat Makkapati, et al.
Izdano: (2024-05-01)

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy
od: Li Ma, et al.
Izdano: (2017-12-01)

Outcome and toxicities of postmastectomy radiotherapy with integral cervicothoracic thermoplastic mask
od: Hongyan Zhang, et al.
Izdano: (2024-11-01)

Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma
od: Younghee Park, et al.
Izdano: (2023-07-01)

Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis
od: Kuntian Lan, et al.
Izdano: (2022-03-01)

Locoregional recurrence after neoadjuvant versus adjuvant chemotherapy based on tumor subtypes in patients with early-stage breast cancer: A multi-institutional retrospective cohort study
od: Jong-Ho Cheun, et al.
Izdano: (2024-12-01)

Patterns of breast cancer locoregional relapse, metastasis, and subtypes in Ghana
od: Gloria Agyekum Boaitey, et al.
Izdano: (2024-12-01)

Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
od: Gang Cai, et al.
Izdano: (2019-07-01)

Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study
od: Yaobin Lin, et al.
Izdano: (2022-05-01)

Conventional versus different hypofractionated radiotherapy dosage schedules in postmastectomy advanced breast cancer
od: Neeraj Jain, et al.
Izdano: (2022-01-01)

Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma
od: Xiao-Yao Feng, et al.
Izdano: (2022-09-01)

Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer
od: Lina Zhang, et al.
Izdano: (2023-08-01)

Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience
od: Besic Nikola, et al.
Izdano: (2018-09-01)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
od: Hongjia Liu, et al.
Izdano: (2023-03-01)

Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review
od: Lei Liu, et al.
Izdano: (2020-01-01)

Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type
od: Tong Q, et al.
Izdano: (2018-06-01)